Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AM.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.15 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.113NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.5.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.423NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.550NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.261NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.3.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EP.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.15.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XCBNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.15.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CM.8.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17723.5South Korea
XSNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.4.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.58NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.631NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.627NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.519NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.514NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GT.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.87NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAPNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.4.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.6.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.123.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.9.2.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EW.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBF.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.37NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EW.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBF.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.132 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.1.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KF.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CS.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.83NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BJ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDGNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used